BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 042278
(73 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 39.7 bits (91), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 26 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 26 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
Complexed With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 23 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A
Complexed With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A
F82h-L83v- H84d Mutant With An
O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 21 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active
Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 20 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin
B
Length = 289
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 23 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 20 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 21 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 20 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 20 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 21 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 21 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr
160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin
A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 20 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN
OXINDOLE Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu-
Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Dph- 042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Din- 234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With
Din- 232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And
Inactive Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin
Binding Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With
Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE
INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of
Cdk2, Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor
Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 22 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 39.3 bits (90), Expect = 5e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
Length = 299
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex
With A Peptide Containing Both The Substrate And
Recruitment Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN
COMPLEX With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 39.3 bits (90), Expect = 6e-04, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 34/51 (66%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+K++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 37.0 bits (84), Expect = 0.002, Method: Composition-based stats.
Identities = 16/51 (31%), Positives = 33/51 (64%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+ ++ ++ + + S E++ L +NHPNI++L D
Sbjct: 19 VYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 37.0 bits (84), Expect = 0.002, Method: Composition-based stats.
Identities = 16/51 (31%), Positives = 33/51 (64%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA + +G+VVA+ ++ ++ + + S E++ L +NHPNI++L D
Sbjct: 18 VYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY
KINASES BY Mimicking Host Substrates
Length = 319
Score = 35.8 bits (81), Expect = 0.005, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ + +NHPNI++LF+
Sbjct: 26 ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 35.8 bits (81), Expect = 0.005, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ + +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 35.8 bits (81), Expect = 0.005, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ + +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 35.8 bits (81), Expect = 0.005, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ + +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 35.0 bits (79), Expect = 0.011, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAV+ + +LN L E+ + +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 35.0 bits (79), Expect = 0.011, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAV+ + +LN L E+ + +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 34.7 bits (78), Expect = 0.014, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 27/48 (56%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ +NHPNI++LF+
Sbjct: 33 ARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 34.3 bits (77), Expect = 0.017, Method: Composition-based stats.
Identities = 18/48 (37%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VAVK + +LN L E+ + +NHPNI++LF+
Sbjct: 34 ARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 34.3 bits (77), Expect = 0.020, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VA+K + +LN L E+ + +NHPNI++LF+
Sbjct: 34 ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 34.3 bits (77), Expect = 0.020, Method: Composition-based stats.
Identities = 17/48 (35%), Positives = 28/48 (58%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
A H+ +G VA+K + +LN L E+ + +NHPNI++LF+
Sbjct: 31 ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 33.5 bits (75), Expect = 0.029, Method: Composition-based stats.
Identities = 14/34 (41%), Positives = 24/34 (70%), Gaps = 4/34 (11%)
Query: 22 VEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+EK ++ + + E++ L S++HPNII+LFD F
Sbjct: 86 IEKFHEEIYN----EISLLKSLDHPNIIKLFDVF 115
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 33.5 bits (75), Expect = 0.029, Method: Composition-based stats.
Identities = 21/66 (31%), Positives = 37/66 (56%), Gaps = 5/66 (7%)
Query: 2 TLWKAEHLSSGDVVAVKQVYV----EKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
T++KA ++ +VA+K++ + E + ++ L E+ L ++HPNII L DAF
Sbjct: 25 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGH 83
Query: 58 GCGISI 63
IS+
Sbjct: 84 KSNISL 89
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 33.5 bits (75), Expect = 0.029, Method: Composition-based stats.
Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 3/67 (4%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFPPGCG 60
+++A L G VA+K+V + L K+ DC E++ L +NHPN+I+ + +F
Sbjct: 48 VYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106
Query: 61 ISIWLSL 67
++I L L
Sbjct: 107 LNIVLEL 113
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 33.5 bits (75), Expect = 0.035, Method: Composition-based stats.
Identities = 18/53 (33%), Positives = 34/53 (64%), Gaps = 2/53 (3%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
++KA++ + V+A +V K + L+ + E++ L+S +HPNI++L DAF
Sbjct: 53 VYKAQNKET-SVLAAAKVIDTKSEEELEDYM-VEIDILASCDHPNIVKLLDAF 103
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 33.1 bits (74), Expect = 0.035, Method: Composition-based stats.
Identities = 18/53 (33%), Positives = 34/53 (64%), Gaps = 2/53 (3%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
++KA++ + V+A +V K + L+ + E++ L+S +HPNI++L DAF
Sbjct: 53 VYKAQNKET-SVLAAAKVIDTKSEEELEDYM-VEIDILASCDHPNIVKLLDAF 103
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 33.1 bits (74), Expect = 0.035, Method: Composition-based stats.
Identities = 18/53 (33%), Positives = 34/53 (64%), Gaps = 2/53 (3%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
++KA++ + V+A +V K + L+ + E++ L+S +HPNI++L DAF
Sbjct: 53 VYKAQNKET-SVLAAAKVIDTKSEEELEDYM-VEIDILASCDHPNIVKLLDAF 103
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 32.7 bits (73), Expect = 0.046, Method: Composition-based stats.
Identities = 18/53 (33%), Positives = 34/53 (64%), Gaps = 2/53 (3%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
++KA++ + V+A +V K + L+ + E++ L+S +HPNI++L DAF
Sbjct: 26 VYKAQNKET-SVLAAAKVIDTKSEEELEDYM-VEIDILASCDHPNIVKLLDAF 76
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 32.7 bits (73), Expect = 0.054, Method: Composition-based stats.
Identities = 14/44 (31%), Positives = 28/44 (63%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
S G +VA+K++ ++ ++ + S E++ L ++HPNI+ L D
Sbjct: 43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 32.7 bits (73), Expect = 0.054, Method: Composition-based stats.
Identities = 14/44 (31%), Positives = 28/44 (63%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
S G +VA+K++ ++ ++ + S E++ L ++HPNI+ L D
Sbjct: 43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 32.7 bits (73), Expect = 0.056, Method: Composition-based stats.
Identities = 15/51 (29%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA++ + G+ A+K++ +EK ++ + S E++ L + H NI++L+D
Sbjct: 18 VYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 32.7 bits (73), Expect = 0.057, Method: Composition-based stats.
Identities = 15/51 (29%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA++ + G+ A+K++ +EK ++ + S E++ L + H NI++L+D
Sbjct: 18 VYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 32.7 bits (73), Expect = 0.057, Method: Composition-based stats.
Identities = 15/51 (29%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
++KA++ + G+ A+K++ +EK ++ + S E++ L + H NI++L+D
Sbjct: 18 VYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 32.3 bits (72), Expect = 0.063, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 25/49 (51%)
Query: 5 KAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
K S G ++ K++ + + K L E+N L + HPNI+R +D
Sbjct: 24 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 32.3 bits (72), Expect = 0.063, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 25/49 (51%)
Query: 5 KAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
K S G ++ K++ + + K L E+N L + HPNI+R +D
Sbjct: 24 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 32.3 bits (72), Expect = 0.063, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 25/49 (51%)
Query: 5 KAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
K S G ++ K++ + + K L E+N L + HPNI+R +D
Sbjct: 24 KIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By
5z-7-oxozeaenol
Length = 315
Score = 32.3 bits (72), Expect = 0.063, Method: Composition-based stats.
Identities = 22/57 (38%), Positives = 29/57 (50%), Gaps = 11/57 (19%)
Query: 4 WKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA-FPPGC 59
W+A+ VA+KQ+ E K EL LS VNHPNI++L+ A P C
Sbjct: 30 WRAKD------VAIKQIESESERK----AFIVELRQLSRVNHPNIVKLYGACLNPVC 76
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 32.3 bits (72), Expect = 0.065, Method: Composition-based stats.
Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 10/51 (19%)
Query: 4 WKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
W+A+ VA+KQ+ E K EL LS VNHPNI++L+ A
Sbjct: 29 WRAKD------VAIKQIESESERK----AFIVELRQLSRVNHPNIVKLYGA 69
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 32.3 bits (72), Expect = 0.072, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 33/54 (61%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
T++KA++ + ++VA+K+V ++ ++ + S E+ L + H NI+RL D
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL 70
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 32.3 bits (72), Expect = 0.074, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 33/54 (61%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
T++KA++ + ++VA+K+V ++ ++ + S E+ L + H NI+RL D
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL 70
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From
Yeast Snf1
Length = 274
Score = 32.0 bits (71), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 32/49 (65%), Gaps = 1/49 (2%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNK-HLKSCLDCELNFLSSVNHPNIIRLFD 53
A H ++G VA+K + + L K ++ ++ E+++L + HP+II+L+D
Sbjct: 27 AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 32.0 bits (71), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 32/49 (65%), Gaps = 1/49 (2%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNK-HLKSCLDCELNFLSSVNHPNIIRLFD 53
A H ++G VA+K + + L K ++ ++ E+++L + HP+II+L+D
Sbjct: 32 AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain
Of The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 31.6 bits (70), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 32/49 (65%), Gaps = 1/49 (2%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNK-HLKSCLDCELNFLSSVNHPNIIRLFD 53
A H ++G VA+K + + L K ++ ++ E+++L + HP+II+L+D
Sbjct: 23 AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 31.6 bits (70), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 16/49 (32%), Positives = 32/49 (65%), Gaps = 1/49 (2%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNK-HLKSCLDCELNFLSSVNHPNIIRLFD 53
A H ++G VA+K + + L K ++ ++ E+++L + HP+II+L+D
Sbjct: 33 AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
>pdb|3GNI|B Chain B, Structure Of Strad And Mo25
Length = 389
Score = 31.6 bits (70), Expect = 0.13, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 28/49 (57%)
Query: 1 MTLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNII 49
MT+ A + +G+ V V+++ +E + + + L EL+ NHPNI+
Sbjct: 41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 20/32 (62%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSL 67
E+ + S++HPNIIRL++ F I + + L
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 12/32 (37%), Positives = 20/32 (62%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSL 67
E+ + S++HPNIIRL++ F I + + L
Sbjct: 73 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 104
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 5/57 (8%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
SS DV + ++ V+KL++ +S + EL L + H N+I L D F P +
Sbjct: 69 SSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSL 125
>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric
Lkb1-Stradalpha-Mo25alpha Complex
pdb|2WTK|E Chain E, Structure Of The Heterotrimeric
Lkb1-Stradalpha-Mo25alpha Complex
Length = 373
Score = 31.2 bits (69), Expect = 0.14, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 28/49 (57%)
Query: 1 MTLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNII 49
MT+ A + +G+ V V+++ +E + + + L EL+ NHPNI+
Sbjct: 25 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 73
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 31.2 bits (69), Expect = 0.15, Method: Composition-based stats.
Identities = 15/49 (30%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 7 EHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
E SSG +K + ++ ++ ++ E+ L S++HPNII++F+ F
Sbjct: 42 EERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFEVF 89
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 30.8 bits (68), Expect = 0.18, Method: Composition-based stats.
Identities = 15/55 (27%), Positives = 34/55 (61%), Gaps = 6/55 (10%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+++KA H +G +VA+KQV VE L + +K E++ + + P++++ + ++
Sbjct: 44 SVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPHVVKYYGSY 93
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 30.8 bits (68), Expect = 0.20, Method: Composition-based stats.
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 5/57 (8%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
S+ D ++V V+KL++ +S + EL L + H N+I L D F P I
Sbjct: 46 SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSI 102
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 30.8 bits (68), Expect = 0.20, Method: Composition-based stats.
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 5/57 (8%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
S+ D ++V V+KL++ +S + EL L + H N+I L D F P I
Sbjct: 46 SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSI 102
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 30.8 bits (68), Expect = 0.20, Method: Composition-based stats.
Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 5/57 (8%)
Query: 10 SSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
S+ D ++V V+KL++ +S + EL L + H N+I L D F P I
Sbjct: 38 SAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSI 94
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 30.0 bits (66), Expect = 0.38, Method: Composition-based stats.
Identities = 13/53 (24%), Positives = 28/53 (52%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
++K + +G +VA+K+ + + +K E+ L + HPN++ L + F
Sbjct: 19 VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF 71
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein
Kinase 3 (Dapk3) In Complex With A Beta-Carboline
Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein
Kinase 3 (Dapk3) In Complex With An Imidazo-Pyridazine
Ligand
Length = 283
Score = 29.6 bits (65), Expect = 0.40, Method: Composition-based stats.
Identities = 13/33 (39%), Positives = 18/33 (54%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSLI 68
E+N L + HPNII L D F + + L L+
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELV 90
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 29.6 bits (65), Expect = 0.40, Method: Composition-based stats.
Identities = 13/33 (39%), Positives = 18/33 (54%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSLI 68
E+N L + HPNII L D F + + L L+
Sbjct: 79 EVNILREIRHPNIITLHDIFENKTDVVLILELV 111
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 29.6 bits (65), Expect = 0.40, Method: Composition-based stats.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
VAVK + L+ L E N L VNHP++I+L+ A
Sbjct: 56 VAVKMLKENASPSELRDLLS-EFNVLKQVNHPHVIKLYGA 94
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 29.6 bits (65), Expect = 0.40, Method: Composition-based stats.
Identities = 13/33 (39%), Positives = 18/33 (54%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSLI 68
E+N L + HPNII L D F + + L L+
Sbjct: 65 EVNILREIRHPNIITLHDIFENKTDVVLILELV 97
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 29.6 bits (65), Expect = 0.41, Method: Composition-based stats.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
VAVK + L+ L E N L VNHP++I+L+ A
Sbjct: 56 VAVKMLKENASPSELRDLLS-EFNVLKQVNHPHVIKLYGA 94
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 29.6 bits (65), Expect = 0.42, Method: Composition-based stats.
Identities = 16/40 (40%), Positives = 22/40 (55%), Gaps = 1/40 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
VAVK + L+ L E N L VNHP++I+L+ A
Sbjct: 56 VAVKMLKENASPSELRDLLS-EFNVLKQVNHPHVIKLYGA 94
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.42, Method: Composition-based stats.
Identities = 20/55 (36%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
T++KA SG VA+K V V + L E L L + HPN++RL D
Sbjct: 19 TVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.42, Method: Composition-based stats.
Identities = 20/55 (36%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
T++KA SG VA+K V V + L E L L + HPN++RL D
Sbjct: 19 TVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type
Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.42, Method: Composition-based stats.
Identities = 20/55 (36%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
T++KA SG VA+K V V + L E L L + HPN++RL D
Sbjct: 19 TVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 29.6 bits (65), Expect = 0.44, Method: Composition-based stats.
Identities = 13/41 (31%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
VA+K++ +EK + L E+ +S +HPNI+ + +F
Sbjct: 38 VAIKRINLEKCQTSMDELLK-EIQAMSQCHHPNIVSYYTSF 77
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 29.6 bits (65), Expect = 0.44, Method: Composition-based stats.
Identities = 13/41 (31%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
VA+K++ +EK + L E+ +S +HPNI+ + +F
Sbjct: 43 VAIKRINLEKCQTSMDELLK-EIQAMSQCHHPNIVSYYTSF 82
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 78
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 41 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 83
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 64 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 106
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 74 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 116
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 72 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 114
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 55 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 97
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 115 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 157
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 44 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 86
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 48 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 90
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b
Inhibitor That Attenuates Hyperactivity In Clock Mutant
Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 78
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 48 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 90
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 40 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 82
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 78
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 37 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 79
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 78
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 29.3 bits (64), Expect = 0.53, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V +K K+ EL + ++H NI+RL
Sbjct: 49 VYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 91
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 29.3 bits (64), Expect = 0.54, Method: Composition-based stats.
Identities = 16/45 (35%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL+K +S + EL L + H N+I L D F P
Sbjct: 61 RVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 105
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 29.3 bits (64), Expect = 0.64, Method: Composition-based stats.
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPPGCGISIWL 65
AE + +VA+K + E L + ++ E+ L + HPNI+ L D + G + + +
Sbjct: 37 AEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 66 SLI 68
L+
Sbjct: 96 QLV 98
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 28.9 bits (63), Expect = 0.66, Method: Composition-based stats.
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPPGCGISIWL 65
AE + +VA+K + E L + ++ E+ L + HPNI+ L D + G + + +
Sbjct: 37 AEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 66 SLI 68
L+
Sbjct: 96 QLV 98
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 28.9 bits (63), Expect = 0.67, Method: Composition-based stats.
Identities = 17/63 (26%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPPGCGISIWL 65
AE + +VA+K + E L + ++ E+ L + HPNI+ L D + G + + +
Sbjct: 37 AEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 66 SLI 68
L+
Sbjct: 96 QLV 98
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 28.9 bits (63), Expect = 0.77, Method: Composition-based stats.
Identities = 16/51 (31%), Positives = 31/51 (60%), Gaps = 5/51 (9%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNK---HLKSCLDCELNFLSSVNHPNIIRLFD 53
A H + VA+K + + L K H++ ++ E+++L + HP+II+L+D
Sbjct: 28 ATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLRHPHIIKLYD 76
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor,
Sr-3737
Length = 364
Score = 28.5 bits (62), Expect = 0.90, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTP 94
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 28.5 bits (62), Expect = 0.98, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTP 94
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted
Quinoline Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted
Quinoline Inhibitor
Length = 356
Score = 28.5 bits (62), Expect = 0.98, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 87
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 28.5 bits (62), Expect = 0.99, Method: Composition-based stats.
Identities = 15/43 (34%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKS-CLDCELNFLSSVNHPNII 49
H +G+ VA+KQ E K+ + CL E+ + +NHPN++
Sbjct: 36 HQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPNVV 76
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 94
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 15/43 (34%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKS-CLDCELNFLSSVNHPNII 49
H +G+ VA+KQ E K+ + CL E+ + +NHPN++
Sbjct: 35 HQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPNVV 75
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 60 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 104
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 14/52 (26%), Positives = 31/52 (59%), Gaps = 1/52 (1%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFD 53
T++K + ++G VA+K+V ++ + + E++ + + H NI+RL+D
Sbjct: 20 TVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHENIVRLYD 70
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTP 94
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Biphenyl Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 61 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 105
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Mapk Docking Peptide
Length = 362
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 51 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 95
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 60 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 104
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 69 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 113
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 72 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 116
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 61 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 105
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 68 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 112
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 24/47 (51%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
H ++G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 50 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 54 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 98
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 54 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 98
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 69 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 113
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Biphenyl Amide Inhibitor
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 68 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 112
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 39 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 88
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 55 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 99
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 72 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 116
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 69 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 113
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 59 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 103
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 51 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 95
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole
Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex
With A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 51 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 95
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants
In Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 56 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants
In Response To Inhibitor Binding
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 56 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 54 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 98
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 48 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 92
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 56 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 56 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals
A Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A
Selective Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2
Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen
Activated Protein Kinase P38 (P38 Map Kinase) The
Mammalian Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino- Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein
Kinase In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 55 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 99
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three
Clinical P38alpha Inhibitors
Length = 362
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 51 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 95
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha
Map Kinase
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 47 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 91
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog
In Complex With P38 Map Kinase
Length = 360
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based
Assessment Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based
Assessment Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 46 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 95
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 39 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 88
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 28.5 bits (62), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 87
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 46 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 90
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With
The Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 3 LWKAEHLSSGD-VVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
++KA L +G VA+K+V V+ + + E L L + HPN++RLFD
Sbjct: 27 VFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 46 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 90
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 3 LWKAEHLSSGD-VVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
++KA L +G VA+K+V V+ + + E L L + HPN++RLFD
Sbjct: 27 VFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With
1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 83 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 132
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 3 LWKAEHLSSGD-VVAVKQVYVEKLNKHLKSCLDCE---LNFLSSVNHPNIIRLFD 53
++KA L +G VA+K+V V+ + + E L L + HPN++RLFD
Sbjct: 27 VFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 28.1 bits (61), Expect = 1.1, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 83 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 132
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 46 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 95
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 44 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 93
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 94
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D V + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP 94
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 13/43 (30%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 14 VVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
+VA+K ++ ++ K ++ L E+ + ++HPNI+RL++ F
Sbjct: 50 IVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYF 92
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of
A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP
KINASE COMPLEX IN Solution
Length = 359
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 54 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 98
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 49 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 93
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole
Based Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine
Based Inhibitor
Length = 366
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 55 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 99
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/45 (33%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 19 QVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPG 58
+V V+KL++ +S + EL L + H N+I L D F P
Sbjct: 55 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 99
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 24/47 (51%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
H ++G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 27 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 24/47 (51%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
H ++G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 26 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 29/49 (59%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRL 78
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 29/49 (59%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRL 78
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 29/49 (59%), Gaps = 6/49 (12%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
+++A+ SG++VA+K+V K K+ EL + ++H NI+RL
Sbjct: 36 VYQAKLCDSGELVAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRL 78
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 28.1 bits (61), Expect = 1.3, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 24/47 (51%)
Query: 8 HLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
H ++G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 27 HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 28.1 bits (61), Expect = 1.4, Method: Composition-based stats.
Identities = 13/43 (30%), Positives = 27/43 (62%), Gaps = 1/43 (2%)
Query: 14 VVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++A+K ++ +L K ++ L E+ S + HPNI+R+++ F
Sbjct: 41 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And
Inhibition By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And
Inhibition By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 28.1 bits (61), Expect = 1.4, Method: Composition-based stats.
Identities = 13/43 (30%), Positives = 27/43 (62%), Gaps = 1/43 (2%)
Query: 14 VVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++A+K ++ +L K ++ L E+ S + HPNI+R+++ F
Sbjct: 41 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 28.1 bits (61), Expect = 1.4, Method: Composition-based stats.
Identities = 13/43 (30%), Positives = 27/43 (62%), Gaps = 1/43 (2%)
Query: 14 VVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++A+K ++ +L K ++ L E+ S + HPNI+R+++ F
Sbjct: 42 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 84
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 28.1 bits (61), Expect = 1.4, Method: Composition-based stats.
Identities = 14/39 (35%), Positives = 22/39 (56%)
Query: 30 KSCLDCELNFLSSVNHPNIIRLFDAFPPGCGISIWLSLI 68
K + E+ L ++HPNII+L + F IS+ L L+
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 27.7 bits (60), Expect = 1.5, Method: Composition-based stats.
Identities = 12/22 (54%), Positives = 13/22 (59%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPP 57
EL L VNH NII L + F P
Sbjct: 71 ELVLLKCVNHKNIISLLNVFTP 92
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In
Map Kinase Jnk1
Length = 370
Score = 27.7 bits (60), Expect = 1.7, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 27.7 bits (60), Expect = 1.7, Method: Composition-based stats.
Identities = 12/22 (54%), Positives = 13/22 (59%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPP 57
EL L VNH NII L + F P
Sbjct: 73 ELVLLKCVNHKNIISLLNVFTP 94
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In
Map Kinase Jnk1
Length = 370
Score = 27.7 bits (60), Expect = 1.8, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 27.7 bits (60), Expect = 1.8, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 47 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 96
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In
Map Kinase Jnk1
Length = 370
Score = 27.7 bits (60), Expect = 1.8, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 27.7 bits (60), Expect = 1.8, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 46 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 95
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 27.3 bits (59), Expect = 1.9, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 27.3 bits (59), Expect = 1.9, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 15/47 (31%), Positives = 23/47 (48%)
Query: 11 SGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
+G VA+K++Y ++ EL L + H N+I L D F P
Sbjct: 49 TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 50 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 99
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 14/51 (27%), Positives = 29/51 (56%), Gaps = 2/51 (3%)
Query: 5 KAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
K E ++G +A K + + K + E++ ++ ++H N+I+L+DAF
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAF 155
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In
Map Kinase Jnk1
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTP 94
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In
Map Kinase Jnk1
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTP 94
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In
Map Kinase Jnk1
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTP 94
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In
Map Kinase Jnk1
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTP 94
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 39 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 88
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 7/51 (13%)
Query: 13 DVVAVKQVYVEKLNK------HLKSCLDCELNFLSSVNHPNIIRLFDAFPP 57
D + + V ++KL++ H K EL + VNH NII L + F P
Sbjct: 45 DAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTP 94
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 27.3 bits (59), Expect = 2.1, Method: Composition-based stats.
Identities = 16/63 (25%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPPGCGISIWL 65
AE + +VA+K + + L + ++ E+ L + HPNI+ L D + G + + +
Sbjct: 37 AEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 66 SLI 68
L+
Sbjct: 96 QLV 98
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 15/54 (27%), Positives = 26/54 (48%)
Query: 2 TLWKAEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
T++K + VA ++ KL K + E L + HPNI+R +D++
Sbjct: 41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSW 94
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 15/46 (32%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 11 SGDVVAVKQVYVEKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+G AVK + ++ K K L E+ L ++HPNI++L++ F
Sbjct: 73 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 118
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 15/46 (32%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 11 SGDVVAVKQVYVEKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+G AVK + ++ K K L E+ L ++HPNI++L++ F
Sbjct: 56 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 101
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumped Kinase
Inhibitor, Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Bumpless Bki Analog
Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma
Gondii (Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 15/46 (32%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 11 SGDVVAVKQVYVEKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+G AVK + ++ K K L E+ L ++HPNI++L++ F
Sbjct: 50 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 27.3 bits (59), Expect = 2.2, Method: Composition-based stats.
Identities = 15/46 (32%), Positives = 26/46 (56%), Gaps = 1/46 (2%)
Query: 11 SGDVVAVKQVYVEKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
+G AVK + ++ K K L E+ L ++HPNI++L++ F
Sbjct: 74 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 119
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 27.3 bits (59), Expect = 2.4, Method: Composition-based stats.
Identities = 14/46 (30%), Positives = 23/46 (50%)
Query: 9 LSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
+ +G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 26 IPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 27.3 bits (59), Expect = 2.4, Method: Composition-based stats.
Identities = 14/46 (30%), Positives = 23/46 (50%)
Query: 9 LSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
+ +G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 26 IPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 26.9 bits (58), Expect = 2.7, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A +S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240- >arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240- >arg, Met302->leu) In Complex With
1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240- >arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 26.9 bits (58), Expect = 3.0, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 28 VYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An
Inhibitor Discovered Through Site-Directed Dynamic
Tethering
Length = 272
Score = 26.9 bits (58), Expect = 3.0, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 28 VYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 14/44 (31%), Positives = 22/44 (50%)
Query: 11 SGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
+G A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 46 AGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 13/54 (24%), Positives = 28/54 (51%), Gaps = 9/54 (16%)
Query: 3 LWKAEHLSSGDVVAVKQV----YVEKLNKHLKSCLDCELNFLSSVNHPNIIRLF 52
+++ H +GD+ A+K ++ ++ ++ E L +NH NI++LF
Sbjct: 25 VFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-----EFEVLKKLNHKNIVKLF 73
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated
Human Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated
Human Tbk1 Kinase- Uld Domain
Length = 396
Score = 26.9 bits (58), Expect = 3.2, Method: Composition-based stats.
Identities = 13/54 (24%), Positives = 28/54 (51%), Gaps = 9/54 (16%)
Query: 3 LWKAEHLSSGDVVAVKQV----YVEKLNKHLKSCLDCELNFLSSVNHPNIIRLF 52
+++ H +GD+ A+K ++ ++ ++ E L +NH NI++LF
Sbjct: 25 VFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-----EFEVLKKLNHKNIVKLF 73
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
A 5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With
A 5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 29 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 50 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 26 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 26 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase
By A Novel Class Of High Affinity Disubstituted
Pyrimidine Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target
Kinase Selectivity
Length = 272
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 28 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 41 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 94
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective
Imidazopyrazine Inhibitor
Length = 283
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 23 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 76
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 29 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 29 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 29 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 27 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 29 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 50 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 26.6 bits (57), Expect = 3.3, Method: Composition-based stats.
Identities = 16/54 (29%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++ A S ++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 24 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 26.6 bits (57), Expect = 3.9, Method: Composition-based stats.
Identities = 14/43 (32%), Positives = 26/43 (60%), Gaps = 1/43 (2%)
Query: 14 VVAVKQVYVEKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF 55
++A+K ++ +L K ++ L E+ S + HPNI+RL+ F
Sbjct: 32 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 74
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 26.2 bits (56), Expect = 4.4, Method: Composition-based stats.
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 12/62 (19%)
Query: 3 LWKAEHLSSGDVVAVKQVYVEKLNKHLKSC---------LDCELNFLSSVNHPNIIRLFD 53
+W A V VK + EK+ L+ C + E+ LS V H NII++ D
Sbjct: 40 VWTAVDKEKNKEVVVKFIKKEKV---LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96
Query: 54 AF 55
F
Sbjct: 97 IF 98
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 26.2 bits (56), Expect = 4.5, Method: Composition-based stats.
Identities = 16/50 (32%), Positives = 28/50 (56%), Gaps = 1/50 (2%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
AE ++G + AVK + + L K +S ++ E+ L + H NI+ L D +
Sbjct: 41 AEEKATGKLFAVKCIPKKAL-KGKESSIENEIAVLRKIKHENIVALEDIY 89
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 26.2 bits (56), Expect = 4.6, Method: Composition-based stats.
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 5/53 (9%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFD 53
E L D + ++ V+ +NK D E+ L ++HPNI++LF+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of
Cryptosporidium Parvum Calcium Dependent Protein Kinase
In Complex With 3- Mb-Pp1
Length = 287
Score = 26.2 bits (56), Expect = 4.6, Method: Composition-based stats.
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 5/53 (9%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFD 53
E L D + ++ V+ +NK D E+ L ++HPNI++LF+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 26.2 bits (56), Expect = 4.6, Method: Composition-based stats.
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 5/53 (9%)
Query: 6 AEHLSSGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFD 53
E L D + ++ V+ +NK D E+ L ++HPNI++LF+
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase
Domain From D. Discoideum Bound To Appcp
Length = 287
Score = 26.2 bits (56), Expect = 4.7, Method: Composition-based stats.
Identities = 10/24 (41%), Positives = 17/24 (70%), Gaps = 2/24 (8%)
Query: 36 ELNFLSSVNHPNIIRLFDAF--PP 57
E+ +S++NHPNI++L+ PP
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP 96
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain
Bound To Appcp From D. Discoideum
Length = 287
Score = 26.2 bits (56), Expect = 4.7, Method: Composition-based stats.
Identities = 10/24 (41%), Positives = 17/24 (70%), Gaps = 2/24 (8%)
Query: 36 ELNFLSSVNHPNIIRLFDAF--PP 57
E+ +S++NHPNI++L+ PP
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP 96
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 26.2 bits (56), Expect = 4.7, Method: Composition-based stats.
Identities = 10/24 (41%), Positives = 17/24 (70%), Gaps = 2/24 (8%)
Query: 36 ELNFLSSVNHPNIIRLFDAF--PP 57
E+ +S++NHPNI++L+ PP
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP 96
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 26.2 bits (56), Expect = 5.0, Method: Composition-based stats.
Identities = 13/40 (32%), Positives = 23/40 (57%)
Query: 16 AVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF 55
A+K + ++ S L E+ L ++HPNI++L+D F
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 25.8 bits (55), Expect = 5.7, Method: Composition-based stats.
Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 10/56 (17%)
Query: 11 SGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
SG+ VA+K KL++ +S + EL L + H N+I L D F P +
Sbjct: 66 SGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 25.8 bits (55), Expect = 5.7, Method: Composition-based stats.
Identities = 18/56 (32%), Positives = 27/56 (48%), Gaps = 10/56 (17%)
Query: 11 SGDVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPPGCGI 61
SG+ VA+K KL++ +S + EL L + H N+I L D F P +
Sbjct: 48 SGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 25.8 bits (55), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 13 DVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPP 57
D K V ++K+N+ + +DC E+ L+ + IIRL+D P
Sbjct: 47 DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2 In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2 In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2 In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse
Dapk2 In Complex With Amp
Length = 361
Score = 25.8 bits (55), Expect = 6.4, Method: Composition-based stats.
Identities = 12/33 (36%), Positives = 18/33 (54%)
Query: 36 ELNFLSSVNHPNIIRLFDAFPPGCGISIWLSLI 68
E++ L V HPNII L D + + + L L+
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 25.8 bits (55), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 13 DVVAVKQVYVEKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFPP 57
D A K V ++K+N+ + +DC E+ L+ + IIRL D P
Sbjct: 49 DKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIP 98
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 25.8 bits (55), Expect = 6.8, Method: Composition-based stats.
Identities = 12/37 (32%), Positives = 20/37 (54%), Gaps = 1/37 (2%)
Query: 15 VAVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRL 51
VA+K + V K + L CE + + +HPN++ L
Sbjct: 74 VAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVHL 109
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 25.8 bits (55), Expect = 7.0, Method: Composition-based stats.
Identities = 13/39 (33%), Positives = 20/39 (51%)
Query: 16 AVKQVYVEKLNKHLKSCLDCELNFLSSVNHPNIIRLFDA 54
A K + +KL+ L+ E + HPNI+RL D+
Sbjct: 60 AAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 25.4 bits (54), Expect = 8.8, Method: Composition-based stats.
Identities = 20/69 (28%), Positives = 33/69 (47%), Gaps = 6/69 (8%)
Query: 3 LWKAEHLSSGDVVAVKQVYV---EKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFPPGC 59
+WK +G V+AVKQ+ ++ NK + LD L S + P I++ F F
Sbjct: 41 VWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQCFGTFITNT 97
Query: 60 GISIWLSLI 68
+ I + L+
Sbjct: 98 DVFIAMELM 106
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.138 0.437
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 2,314,119
Number of Sequences: 62578
Number of extensions: 68223
Number of successful extensions: 522
Number of sequences better than 100.0: 301
Number of HSP's better than 100.0 without gapping: 142
Number of HSP's successfully gapped in prelim test: 159
Number of HSP's that attempted gapping in prelim test: 380
Number of HSP's gapped (non-prelim): 301
length of query: 73
length of database: 14,973,337
effective HSP length: 43
effective length of query: 30
effective length of database: 12,282,483
effective search space: 368474490
effective search space used: 368474490
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 45 (21.9 bits)